computational and experimental evaluation of linker peptides and thioredoxin fusion tag in cd20-rituximab specific interactions

Background: overexpression of cd20 protein on the surface of b cells in lymphoma can be targeted by several anti-cd20 molecules. the development of accessible interactive epitopes is more favorable than the full-length transmembrane cd20 in the affinity assessment of anti-cd20 monoclonal antibodies (mabs). methods: the sequence of these epitopes was extracted, and the effects of different linker peptides and the location of histidine (his)-tag were computationally analyzed. the impact of thioredoxin (trx)-tag on the folding of the selected construct and its interaction with rituximab was further investigated. the two final expression cassettes were expressed in escherichia coli after optimization of culture conditions for incubation temperature, post-induction time, optical density at the induction time, and concentration of the inducer. elisa evaluated the binding affinity of rituximab towards the recombinant proteins. results: by homology modeling studies, c-terminal his-tagged structures represented more desirable folded structures. validation of the models revealed that cd20 extracellular domain linked by the g4s polypeptide had better stereochemical quality and structural compatibility. it was selected due to its more effective interaction with rituximab showing the highest dissociation constant of 5.8e-09m, which improved after the fusion of trx-tag (7.1e-10m). the most influential parameters in the expression of the two selected proteins were post-induction temperature and optical density at the induction time. homemade elisa assays revealed a slightly higher affinity of rituximab towards the trx-cd20 protein than the cd20/g4s molecule. conclusions: experimental in vitro studies confirmed the computationally calculated affinity of rituximab towards the two designed cd20 constructs. also, the cell-based binding assessment of anti-cd20 mabs could be substituted by the engineered extracellular domain of human cd20 protein.